| Specialty Retail Industry | Consumer Discretionary Sector | Anna Petinova CEO | OTC PINK Exchange | 40435L104 CUSIP |
| US Country | 5 Employees | - Last Dividend | 23 Feb 2018 Last Split | - IPO Date |
HLK Biotech Holding Group, Inc. operates in the biotechnology sector with a focus on the production and sale of biodiesel. It has expanded its business operations to include the acquisition of real estate properties. Originally established as Amelot Holdings, Inc., the company changed its name to HLK Biotech Holding Group, Inc. in February 2018 to reflect its broader focus. Founded in 1998 and based in Norfolk, Virginia, HLK Biotech Holding Group, Inc. engages in its operations through its subsidiaries, showcasing its growth and diversification in its business model.
HLK Biotech Holding Group, Inc. specializes in the production and sale of biodiesel, an environmentally friendly alternative to traditional fossil fuels. This biodiesel is produced using organic and renewable resources, underscoring the company's commitment to sustainable and eco-friendly practices. By focusing on biodiesel, HLK Biotech contributes to reducing carbon footprints and offering a greener solution for energy needs.
In addition to its biotech operations, HLK Biotech Holding Group, Inc. has ventured into the real estate market, acquiring properties. This diversification strategy not only broadens the company's investment portfolio but also stabilizes its revenue streams outside of the biotech industry. These real estate activities further establish HLK Biotech as a multifaceted corporation with interests in both biotechnology and real estate development.